Mersana Therapeutics, Inc. (MRSN)
28.93
+0.28
(+0.98%)
USD |
NASDAQ |
Dec 31, 16:00
28.92
-0.01
(-0.03%)
After-Hours: 20:00
Mersana Therapeutics Research and Development Expense (TTM): 68.92M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Cidara Therapeutics, Inc. | 131.82M |
| Day One Biopharmaceuticals, Inc. | 169.01M |
| Semler Scientific, Inc. | 4.691M |
| Cue Biopharma, Inc. | 28.14M |
| Scholar Rock Holding Corp. | 210.30M |